Notice of Intent to Sole Source – Biomerieux
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH) intends to award a fixed-price sole source purchase order to BioMerieux for reagent kits used in clinical testing at the NIH Clinical Center (CC) Department of Laboratory Medicine (DLM) in Bethesda, MD. This is a Notice of Intent, not a request for quotation, and a solicitation will not be issued.
Scope of Work
The requirement is for the new purchase of reagent kits essential for clinical testing. These kits are specifically designed for use with existing BioMerieux instrumentation (NucliSENS easyMAG and bioMérieux EMAG) within the DLM. These instruments facilitate rapid, efficient, and sensitive detection of nucleic acid (DNA) from clinical samples, crucial for timely identification of infectious agents.
Contract & Timeline
- Type: Fixed-Price Purchase Order (Sole Source)
- Proposed Vendor: BioMerieux, Inc.
- Set-Aside: None (Sole Source Justification)
- Response Due: March 25, 2026, 9am EST
- Published: March 18, 2026
- Place of Performance: Bethesda, MD 20892, USA
- Product Service Code (PSC): 6515 – Medical And Surgical Instruments, Equipment, And Supplies
- NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing
Justification & Process
The NIH justifies this sole source acquisition under FAR Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), citing that BioMerieux is the sole manufacturer, vendor, and service provider for the existing instrumentation. Consequently, they are the only source for compatible reagents and supplies. Contracts under FAR Part 13 are exempt from FAR Part 6 competition requirements.
Action Items
Interested parties may identify their interest and capabilities in response to this notice. However, the Government's determination not to compete this requirement based on responses is solely at its discretion. Comments should reference the posting number and be submitted via email to Kristin Nagashima (Kristin.nagashima@nih.gov) by the closing date.